The Journal of Rare Diseases and Orphan Drugs (JRDOD) is part of CrossCheck, an initiative to help editors verify the originality of submitted manuscripts. As part of this process, selected submitted manuscripts are scanned and compared with the CrossCheck database.
Plagiarism occurs when someone steals and passes off the ideas or words of another as one's own or uses another's production without crediting the source. Duplicate publication, called self-plagiarism, occurs when an author reuses substantial parts of his or her own published work without providing the appropriate references. This can range from getting an identical paper published in multiple journals, to adding small amounts of new data to a previous paper.
The Journal of Rare Diseases and Orphan Drugs (JRDOD) editors will judge any case of plagiarism on its limits. If plagiarism is detected by an editorial board member, reviewer, or editor in any stage of the article process, before or after acceptance, we will alert the author(s) and ask them to rewrite the content or cite the appropriate references. If more than 30% of the paper is plagiarized, the article will be rejected, and the author will be notified.
All the submitted manuscripts for publication are currently checked for plagiarism after submission and before starting the review process.